01177.HK
Sino Biopharmaceutical Limited
HKSE · Healthcare · Biotechnology · HK
HKD 4.85
−0.10%Leverage
- Debt / equity
- 0.53x
- Net debt / equity
- 0.07x
- Debt / assets
- 0.21x
- Debt / EBITDA
- 1.61x
- Net debt / EBITDA
- 0.21x
Liquidity & coverage
- Current ratio
- 1.63x
- Quick ratio
- 1.56x
- Cash ratio
- 1.02x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- HKD 20.0B
Cash & dividend
- FCF / debt
- 0.30x
- Cash flow / debt
- 0.36x
- Dividend per share
- HKD 0.12
- Dividend yield
- 2.5%
- Dividend growth 1y
- +33.3%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026